- Home
- Publications
- Publication Search
- Publication Details
Title
Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies
Authors
Keywords
Churg−Strauss syndrome, Therapeutics, Rituximab, Omalizumab, Mepolizumab
Journal
Current Rheumatology Reports
Volume 20, Issue 5, Pages -
Publisher
Springer Nature
Online
2018-04-02
DOI
10.1007/s11926-018-0736-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis
- (2017) Loïc Guillevin Nature Reviews Rheumatology
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
- (2017) Michael E. Wechsler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors
- (2017) Xavier Puéchal et al. Arthritis & Rheumatology
- Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis
- (2017) Jens Thiel et al. Journal of Allergy and Clinical Immunology-In Practice
- Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients
- (2016) Marie Jachiet et al. Arthritis & Rheumatology
- Churg–Strauss syndrome
- (2015) Antonio Greco et al. AUTOIMMUNITY REVIEWS
- Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management
- (2015) Matthieu Groh et al. European Journal of Internal Medicine
- Allergen-induced airway responses
- (2015) Gail M. Gauvreau et al. EUROPEAN RESPIRATORY JOURNAL
- Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study
- (2015) Aikaterini Detoraki et al. JOURNAL OF ASTHMA
- Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty-Five Years or Older: Results of a Multicenter, Open-Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide-Based Induction Therapy
- (2015) Christian Pagnoux et al. Arthritis & Rheumatology
- Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
- (2014) A J Mohammad et al. ANNALS OF THE RHEUMATIC DISEASES
- Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg–Strauss syndrome)
- (2014) Luc Mouthon et al. JOURNAL OF AUTOIMMUNITY
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art
- (2013) A. Vaglio et al. ALLERGY
- Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis
- (2013) Kirsten de Groot ANNALS OF INTERNAL MEDICINE
- Targeting Interleukin-5 in Refractory and Relapsing Churg–Strauss Syndrome
- (2013) Frank Moosig et al. ANNALS OF INTERNAL MEDICINE
- Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials
- (2013) Maxime Samson et al. JOURNAL OF AUTOIMMUNITY
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
- (2013) Jens Thiel et al. ARTHRITIS RESEARCH & THERAPY
- Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
- (2012) Peter Valent et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased production of IL-5 and dominant Th2-type response in airways of Churg–Strauss syndrome patients
- (2012) Bogdan Jakiela et al. RHEUMATOLOGY
- The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)
- (2010) Alfonse T. Masi et al. ARTHRITIS AND RHEUMATISM
- Sustained response to mepolizumab in refractory Churg-Strauss syndrome
- (2010) Jean-Emmanuel Kahn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
- (2010) Sophia Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Churg-Strauss Syndrome in Patients Treated With Omalizumab
- (2009) Michael E. Wechsler et al. CHEST
- Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
- (2008) Christian Pagnoux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Churg–Strauss syndrome associated with omalizumab
- (2007) Xavier Puéchal et al. European Journal of Internal Medicine
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started